SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)
Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes have optimized treatment decisions based on risk assessment, molecular profiling, and imaging assessment, leading the development of targeted agents that have modified the natural history of this disease. This increasing complexity on treatment options requires careful assessment at the different stages of the disease to provide the most suitable approach from diagnosis to long-term follow-up. This guideline aims to offer a comprehensive and practical overview on the current status and last updates of TC management.
Authors
- Lara Iglesias Docampo
- Javier Martínez‐Trufero (ORCID: https://orcid.org/0000-0002-0997-2573)
- Neus Basté (ORCID: https://orcid.org/0000-0001-5115-4569)
- Jorge Hernando (ORCID: https://orcid.org/0000-0002-0929-7360)
- Ignacio Porras
- Paula Jiménez‐Fonseca (ORCID: https://orcid.org/0000-0003-4592-3813)
- Jordi Rubió‐Casadevall (ORCID: https://orcid.org/0000-0002-3516-6970)
- Teresa Alonso‐Gordoa (ORCID: https://orcid.org/0000-0002-8966-7236)
- M Navarro (ORCID: https://orcid.org/0000-0003-3502-0805)
- M. Arregui Valles
Institutions
- Hebron University (PS)
- Hospital General Universitario Gregorio Marañón (ES)
- Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
- Complejo Hospitalario de Salamanca (ES)
- Hospital Universitario 12 De Octubre (ES)
- Institut d'Investigació Biomèdica de Girona (ES)
- Hospital Universitario Miguel Servet (ES)
- Hospital Clínic de Barcelona (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Hospital Universitario Central de Asturias (ES)
- Instituto de Investigación Biomédica de Salamanca (ES)
- Hospital Universitario Ramón y Cajal (ES)
Publication Details
- Journal
- Clinical & Translational Oncology
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1007/s12094-024-03736-6
- Citations
- 3
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.07